Mubadala Bio, Eli Lilly lead UAE dealmaking spree in healthcare
The UAE has embraced GLP-1 weight-loss drugs and was an early launch market for Eli Lilly’s Mounjaro injector pen following its FDA approval
Peter Dazeley/Getty Images
Eli Lilly's Foundayo weight loss pills and Mounjaro injection pen will be packaged in the UAE by Mubadala Bio
Mubadala Bio, the life sciences arm of Abu Dhabi’s sovereign wealth fund, signed a deal with Eli Lilly to localize packaging and logistics for the U.S. pharmaceutical company’s blockbuster GLP-1 obesity and diabetes treatments.
The agreement, announced at...